Updates & Highlights
Stock Titan · 5 days ago
Nautilus Biotechnology (NAUT) investors approve directors, auditor and annual Say on Pay
TradingKey · 6 days ago
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis
TradingKey · 6 days ago
Nautilus Biotechnology Inc (NAUT) Institutional Confidence
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Nautilus Biotechnology?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentNautilus Biotechnology (NAUT) investors approve directors, auditor and annual Say on Pay
Nautilus Biotechnology (NAUT) investors approve directors, auditor and annual Say on Pay
Stock Titan · 5 days ago
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis
TradingKey · 6 days ago
Nautilus Biotechnology Inc (NAUT) Institutional Confidence
Nautilus Biotechnology Inc (NAUT) Institutional Confidence
TradingKey · 6 days ago
Nautilus Biotechnology Inc (NAUT) Earnings Forecast: Future EPS & Revenue Growth Estimates
Nautilus Biotechnology Inc (NAUT) Earnings Forecast: Future EPS & Revenue Growth Estimates
TradingKey · 6 days ago
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline
TradingKey · 7 days ago
NAUT Stock Chart | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT)
NAUT Stock Chart | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT)
ChartMill · 19 days ago
Nautilus Biotechnology | 4: Statement of changes in beneficial ownership of securities-10% Owner AH Equity Partners Bio II, L.L.C. - moomoo
Nautilus Biotechnology | 4: Statement of changes in beneficial ownership of securities-10% Owner AH Equity Partners Bio II, L.L.C. - moomoo
Moomoo · 20 days ago
NAUT Stock Price, Quote & Chart | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT)
NAUT Stock Price, Quote & Chart | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT)
ChartMill · about 1 month ago
Nautilus Biotechnology - 2026 Funding Rounds & List of Investors
Nautilus Biotechnology - 2026 Funding Rounds & List of Investors
Tracxn · about 1 month ago
Nautilus Biotechnology Decline Means Insider Profits Down To US$432k
Nautilus Biotechnology Decline Means Insider Profits Down To US$432k
Moomoo · about 1 month ago
Nautilus Biotechnology introduces Voyager Platform for precise tau proteoform analysis
Nautilus Biotechnology introduces Voyager Platform for precise tau proteoform analysis
Traders Union · about 1 month ago
Nautilus Biotechnology unveils Voyager Platform for quantifying 768 tau proteoforms at Tau Global 2026
Nautilus Biotechnology unveils Voyager Platform for quantifying 768 tau proteoforms at Tau Global 2026
Traders Union · about 1 month ago
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans
Yahoo Finance · about 2 months ago
Nautilus Biotechnology (NAUT) price target increased by 60.00% to 4.08
Nautilus Biotechnology (NAUT) price target increased by 60.00% to 4.08
MSN · about 2 months ago
Nautilus Biotechnology Q1 net loss narrows as expenses fall
Nautilus Biotechnology Q1 net loss narrows as expenses fall
TradingView · about 2 months ago
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
ChartMill · about 2 months ago
Nautilus Biotechnology 10-Q: $0.0M Revenue, $(0.12) EPS for Q1 2026
Nautilus Biotechnology 10-Q: $0.0M Revenue, $(0.12) EPS for Q1 2026
TradingView · about 2 months ago
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Yahoo Finance · about 2 months ago
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Investing News Network · about 2 months ago
Nautilus Biotechnology Q1 Earnings Call Highlights
Nautilus Biotechnology Q1 Earnings Call Highlights
MarketBeat · about 2 months ago